News

Regulatory affairsRegulatory Round-up - March 2026
Filter:AllPress ReleaseCell TherapiesGene TherapiesDigital and AutomationSpin-outs, Start-ups, Sector investmentManufacturingRegulatory affairsSkills and Training
Year:All2026202520242023 →
New survey shows UK cell and gene therapy industry expects workforce to return to growth, following a challenging period of headcount reductionsNew survey shows UK cell and gene therapy industry expects workforce to return to growth, following a challenging period of headcount reductionsRegulatory Round-up - February 2026Regulatory Round-up - February 2026Cross sector collaboration is vital to bringing more life-changing therapies to people with rare diseasesCross sector collaboration is vital to bringing more life-changing therapies to people with rare diseasesCGT Catapult establishes Technology Advisory Board to identify opportunities for the advanced therapies sector to deploy and benefit from innovationsCGT Catapult establishes Technology Advisory Board to identify opportunities for the advanced therapies sector to deploy and benefit from innovationsRegulatory Round-up - January 2026Regulatory Round-up - January 2026R&D project spotlight: Leveraging advanced analytics for detailed process characterisation in iPSC natural killer cell therapy generationR&D project spotlight: Leveraging advanced analytics for detailed process characterisation in iPSC natural killer cell therapy generationNew data shows continued growth in advanced therapy clinical trials in the UK for 2025, with the number of early-stage trials remaining highNew data shows continued growth in advanced therapy clinical trials in the UK for 2025, with the number of early-stage trials remaining highRegulatory Round-up - December 2025Regulatory Round-up - December 2025